Xianqiu Wu

1.1k total citations
26 papers, 740 citations indexed

About

Xianqiu Wu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xianqiu Wu has authored 26 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xianqiu Wu's work include Cancer Cells and Metastasis (5 papers), Epigenetics and DNA Methylation (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Xianqiu Wu is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Epigenetics and DNA Methylation (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Xianqiu Wu collaborates with scholars based in China, United Kingdom and United States. Xianqiu Wu's co-authors include Chuyong Lin, Libing Song, Liping Ye, Yue Li, Yunting Jian, Jun Li, Ying Ouyang, Zhongyu Yuan, Xin Zhang and Dongni Shi and has published in prestigious journals such as Nature Communications, Oncogene and The FASEB Journal.

In The Last Decade

Xianqiu Wu

24 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianqiu Wu China 15 483 223 193 115 93 26 740
Shucai Yang China 13 509 1.1× 317 1.4× 230 1.2× 95 0.8× 154 1.7× 24 793
Wensheng Qiu China 17 518 1.1× 271 1.2× 215 1.1× 162 1.4× 62 0.7× 71 842
Dianyun Ren China 16 419 0.9× 202 0.9× 261 1.4× 141 1.2× 110 1.2× 25 708
Zhenhai Lin China 9 329 0.7× 150 0.7× 143 0.7× 96 0.8× 46 0.5× 15 536
Guangyang Yu China 13 580 1.2× 261 1.2× 221 1.1× 90 0.8× 86 0.9× 17 761
Junwei Song China 14 547 1.1× 287 1.3× 137 0.7× 81 0.7× 74 0.8× 18 712
Timothy Wai Ho Shuen Singapore 12 350 0.7× 201 0.9× 135 0.7× 83 0.7× 77 0.8× 22 563
Fang Zhu China 14 428 0.9× 251 1.1× 214 1.1× 112 1.0× 61 0.7× 41 692
Jian‐Yang Ao China 13 328 0.7× 234 1.0× 179 0.9× 79 0.7× 202 2.2× 25 665

Countries citing papers authored by Xianqiu Wu

Since Specialization
Citations

This map shows the geographic impact of Xianqiu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianqiu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianqiu Wu more than expected).

Fields of papers citing papers by Xianqiu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianqiu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianqiu Wu. The network helps show where Xianqiu Wu may publish in the future.

Co-authorship network of co-authors of Xianqiu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianqiu Wu. A scholar is included among the top collaborators of Xianqiu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianqiu Wu. Xianqiu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sun, Xiaoqing, Caiqin Wang, Jing Li, et al.. (2024). Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance. Journal of Advanced Research. 73. 631–644. 3 indexed citations
3.
Huang, Can, Qingping Li, Biao Wang, et al.. (2024). Accumulation of polyunsaturated lipids fuels ferroptosis to promote liver failure after extended hepatectomy in mice. Free Radical Research. 58(11). 733–747.
4.
Wang, Xiaoqing, Yunyun Xiao, Xinjian Huang, et al.. (2023). The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma. The Journal of Pathology. 260(1). 17–31. 6 indexed citations
5.
Sun, Peng, Hang Yang, Huan Li, et al.. (2023). Pretreatment Soluble Siglec-5 Protein Predicts Early Progression and R-Chop Efficacy in Diffuse Large B-Cell Lymphoma. Biomarkers in Medicine. 17(3). 143–158. 3 indexed citations
6.
Wu, Xianqiu, Bin Wang, Yaorong Su, et al.. (2022). ALG8 Fuels Stemness Through Glycosylation of the WNT/Beta-Catenin Signaling Pathway in Colon Cancer. DNA and Cell Biology. 41(12). 1075–1083. 4 indexed citations
7.
Shi, Dongni, Xianqiu Wu, Yunting Jian, et al.. (2022). USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer. Nature Communications. 13(1). 5644–5644. 120 indexed citations
8.
Sun, Xiaoqing, Zhen‐Yu He, Ling Guo, et al.. (2021). ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 149–149. 50 indexed citations
9.
Sun, Xiaoqing, Caiqin Wang, Cui Chen, et al.. (2021). Combined tumor‐associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma. Hematological Oncology. 39(5). 625–638. 7 indexed citations
10.
Wu, Xianqiu, et al.. (2020). LncRNA TUG1 competitively binds to miR‐340 to accelerate myocardial ischemia‐reperfusion injury. The FASEB Journal. 35(1). e21163–e21163. 22 indexed citations
11.
Sha, Zhou, Shiliang Liu, Chuyong Lin, et al.. (2020). TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ. Oncogene. 39(18). 3710–3725. 22 indexed citations
12.
Li, Han, Weijing Zhang, Chuyong Lin, et al.. (2019). Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway. International Journal of Cancer. 145(7). 1921–1934. 32 indexed citations
13.
Ye, Liping, Chuyong Lin, Xi Wang, et al.. (2019). Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer. EMBO Molecular Medicine. 11(12). e10638–e10638. 62 indexed citations
14.
Cui, Yanmei, Xianqiu Wu, Chuyong Lin, et al.. (2019). AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway. Oncogene. 38(27). 5516–5529. 38 indexed citations
15.
Ye, Liping, Feng‐Yan Li, Yipeng Song, et al.. (2018). Overexpression of CDCA7 predicts poor prognosis and induces EZH2‐mediated progression of triple‐negative breast cancer. International Journal of Cancer. 143(10). 2602–2613. 40 indexed citations
16.
Zhang, Huizhong, Ziyuan Zhu, Xianqiu Wu, et al.. (2018). Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/β-catenin signaling pathway in colorectal cancer. Oncology Reports. 40(3). 1261–1274. 8 indexed citations
17.
Zhang, Xin, Dong Ren, Xianqiu Wu, et al.. (2018). miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways. Molecular Therapy — Nucleic Acids. 11. 142–158. 51 indexed citations
18.
Liu, Junling, Liping Ye, Qingyuan Li, et al.. (2017). Synaptopodin‐2 suppresses metastasis of triple‐negative breast cancer via inhibition of YAP/TAZ activity. The Journal of Pathology. 244(1). 71–83. 41 indexed citations
19.
Wu, Xianqiu, Chao‐Chun Yang, Wentao Wang, et al.. (2017). Nucleolar and spindle associated protein 1 promotes the aggressiveness of astrocytoma by activating the Hedgehog signaling pathway. Journal of Experimental & Clinical Cancer Research. 36(1). 127–127. 47 indexed citations
20.
Wu, Xianqiu, Binkui Li, Jiliang Qiu, et al.. (2015). Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 49(6). 520–528. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026